journal article·2021-01-12

Delivery of CRISPR/Cas9 Plasmids by Cationic Gold Nanorods: Impact of the Aspect Ratio on Genome Editing and Treatment of Hepatic Fibrosis

Yuxuan Chen, Xiaohong Chen, Di Wu, Huhu Xin, Desui Chen, Da Li, Hongming Pan, Changxin Zhou, Yuan Ping

Chemistry of Materials· Volume 33· Issue 1
Publisher page

Abstract

Delivery of CRISPR/Cas9 machineries into living cells and tissues is of paramount importance in a wide range of therapeutic applications, yet the shortage of delivery vectors that can efficiently deliver large CRISPR/Cas9 plasmids has severely impeded its applications from complicated and diverse genome-editing contexts. Herein, we demonstrate that cationic polymer-coated gold nanorods (AuNRs) with a high aspect ratio (AR) exhibit a unique manner to assemble DNA, excellent capability to mediate internalization, and strong ability to escape endosomes. The intracellular delivery mediated by cationic nanorods of a high AR enables Cas9-mediated genome editing and dCas9-mediated transcriptional activation, and in vivo delivery of CRISPR/Cas9 plasmid-targeting Fas by cationic AuNRs can successfully protect the mice from liver fibrosis. The current study reveals how nanomaterials with a particular structure contribute to genome-editing activity and defines a new method for the efficient delivery of CRISPR/Cas9 plasmids.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: CRISPR and Genetic Engineering · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China

Department of Chemistry, Zhejiang University, Hangzhou 310058, China

Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China

Funding

Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province · Central Committee of the Communist Party of China · Zhejiang Society for Mathematical Medicine

References (53)

Show source-provided references
1. 10.1126/science.122582910.1126/science.1225829 ↗
2. 10.1126/science.125809610.1126/science.1258096 ↗
3. 10.1038/nm.379310.1038/nm.3793 ↗
4. 10.1016/j.mattod.2018.12.00310.1016/j.mattod.2018.12.003 ↗
5. 10.1146/annurev-med-081117-01045110.1146/annurev-med-081117-010451 ↗
6. 10.1038/nbt.346910.1038/nbt.3469 ↗
7. 10.1007/s13238-017-0397-310.1007/s13238-017-0397-3 ↗
8. 10.1126/science.aad119110.1126/science.aad1191 ↗
9. 10.1016/j.ymthe.2017.03.01210.1016/j.ymthe.2017.03.012 ↗
10. 10.13918/j.issn.2095-8137.2016.4.20510.13918/j.issn.2095-8137.2016.4.205 ↗
11. 10.1038/nprot.2017.01610.1038/nprot.2017.016 ↗
12. 10.1038/s41592-018-0149-110.1038/s41592-018-0149-1 ↗
13. 10.1038/nature2327010.1038/nature23270 ↗
14. 10.1016/j.ccell.2018.01.01210.1016/j.ccell.2018.01.012 ↗
15. 10.1126/science.123203310.1126/science.1232033 ↗
16. 10.1016/j.cell.2014.02.00110.1016/j.cell.2014.02.001 ↗
17. 10.1038/nbt.348110.1038/nbt.3481 ↗
18. 10.1021/acschembio.7b0076010.1021/acschembio.7b00760 ↗
19. 10.1101/cshperspect.a01274010.1101/cshperspect.a012740 ↗
20. 10.7150/thno.4700710.7150/thno.47007 ↗
21. 10.1002/marc.20180006810.1002/marc.201800068 ↗
22. 10.1073/pnas.191222011710.1073/pnas.1912220117 ↗
23. 10.1038/nature1358910.1038/nature13589 ↗
24. 10.1073/pnas.191597411610.1073/pnas.1915974116 ↗
25. 10.1126/science.367.6474.13110.1126/science.367.6474.131 ↗
26. 10.1038/nbt.314910.1038/nbt.3149 ↗
27. 10.1093/nar/gkv60110.1093/nar/gkv601 ↗
28. 10.1073/pnas.171296311510.1073/pnas.1712963115 ↗
29. 10.1002/anie.20190926410.1002/anie.201909264 ↗
30. 10.1002/adma.20190118710.1002/adma.201901187 ↗
31. 10.1021/acsnano.6b0426110.1021/acsnano.6b04261 ↗
32. 10.1021/jacs.8b1199610.1021/jacs.8b11996 ↗
33. 10.1002/advs.20200142410.1002/advs.202001424 ↗
34. 10.1002/ange.20190361810.1002/ange.201903618 ↗
35. 10.1126/sciadv.aba298310.1126/sciadv.aba2983 ↗
36. 10.1038/s41591-018-0209-110.1038/s41591-018-0209-1 ↗
37. 10.1002/adma.20190257510.1002/adma.201902575 ↗
38. 10.1038/s41565-020-0669-610.1038/s41565-020-0669-6 ↗
39. 10.1002/adma.20200353710.1002/adma.202003537 ↗
40. 10.1002/anie.20200564410.1002/anie.202005644 ↗
41. 10.1016/j.talanta.2018.02.08810.1016/j.talanta.2018.02.088 ↗
42. 10.1039/D0MH00870B10.1039/D0MH00870B ↗
43. 10.1002/adfm.20170125510.1002/adfm.201701255 ↗
44. 10.1002/adfm.20160141810.1002/adfm.201601418 ↗
45. 10.1038/s41551-017-0137-210.1038/s41551-017-0137-2 ↗
46. 10.1002/anie.20171308210.1002/anie.201713082 ↗
47. 10.1016/j.biomaterials.2015.11.02510.1016/j.biomaterials.2015.11.025 ↗
48. 10.1021/acs.chemmater.7b0531010.1021/acs.chemmater.7b05310 ↗
49. 10.1021/nn301211410.1021/nn3012114 ↗
50. 10.1002/smll.20110049710.1002/smll.201100497 ↗
51. 10.1021/acs.nanolett.6b0434610.1021/acs.nanolett.6b04346 ↗
52. 10.1038/nm82810.1038/nm828 ↗
53. 10.1038/nmat426910.1038/nmat4269 ↗